Vitaliy Androshchuk

Interventional cardiologist / Cardiologist
St Thomas’ Hospital - London, United Kingdom

Latest contributions

TAVI: LIVE Educational Case from Cleveland Clinic - London, UK

22 May 2026 – From EuroPCR 2026

This educational session from the Cleveland Clinic focuses on transcatheter aortic valve implantation (TAVI) in patients with significant landing zone calcification. It presents a detailed operator strategy and live case demonstrating the optimal use of a third generation intra-annular self-expanding valve, alongside approaches to coronary artery...

CTO ADVANCED Level II: LIVE Educational Cases from Cleveland Clinic London, UK & University Hospital Basel, Switzerland

21 May 2026 – From EuroPCR 2026

This advanced session presents live educational cases on chronic total occlusions (CTO) from leading centers in London and Basel. Participants gain insights into selecting antegrade versus retrograde approaches, interpreting intravascular imaging for informed decision-making, and integrating sophisticated tools and techniques to enhance procedural success in complex...

TAVI: LIVE Educational Case from Cleveland Clinic - London, UK

21 May 2026 – From EuroPCR 2026

This educational case session from the Cleveland Clinic focuses on lifetime management strategies for severe aortic stenosis, emphasizing optimal valve-in-valve (TAV-in-SAV) procedures. It covers patient assessment, valve selection, procedural techniques, and outcomes to guide management of degenerate surgical bioprostheses.

Is durability still a topic of concern for TAVI patients? What are the remaining challenges that we need to overcome?

20 May 2026 – From EuroPCR 2026

Examine the clinical relevance of TAVI valve durability and its impact on long-term patient management in aortic stenosis. Review key factors influencing valve performance over time, with a focus on procedural and anatomical determinants of optimal outcomes.

Current concepts and techniques aimed at achieving ideal valve expansion...

Is durability still a topic of concern for TAVI patients? What are the remaining challenges that we need to overcome?

Best complications in primary PCI

19 May 2026 – From EuroPCR 2026

This session delves into a spectrum of challenging complications encountered during primary PCI, showcasing advanced management techniques and unique case scenarios. Highlights include managing complex cathlab nightmares, innovative IVUS-guided true lumen re-entry strategies, and critical decision-making in coronary artery dissections.

Next generation TAVI procedural planning

19 May 2026 – From EuroPCR 2026

Explore the forefront of TAVI procedural planning, featuring innovations such as valve-in-valve techniques for sutureless valves, integration of artificial intelligence in heart team decisions, and advanced imaging-guided access methods. The session also examines clinical outcomes related to bicuspid anatomy and prosthesis-patient mismatch, providing a comprehensive view...

TAVI in bicuspid aortic valve disease - LIVE Case

20 May 2025 – From EuroPCR 2025

A 79-year-old male patient with atrial fibrillation and RBBB on ECG presented with symptomatic severe bicuspid aortic stenosis. LV function was preserved, and coronary artery disease was noted in LAD and first diagonal. A 26 mm Sapien Ultra Resilia valve was implanted via dual femoral access,...

TAVI in bicuspid aortic valve disease - LIVE Case

Pioneering innovation in the treatment of mitral and tricuspid regurgitation

20 May 2025 – From EuroPCR 2025

This interventional session explores therapeutic strategies for mitral and tricuspid regurgitation, focusing on the clinical decision-making process between repair and replacement. Through two clinical cases, a 78-year-old male patient with severe degenerative mitral regurgitation and an 88-year-old female patient with atrial functional mitral regurgitation, experts review available...

Pioneering innovation in the treatment of mitral and tricuspid regurgitation